| |
| Bringing a novel therapeutic to market is a complex, time-intensive process — but partnering with the right CDMO can make all the difference. Outsourced Pharma is here to help you find the ideal collaborator for your project. The Outsourced Pharma Capacity Update (OPCU) connects you with leading CDMOs, offering real-time insights into their available capacity, services, and facility updates. This event delivers concise, informative presentations, giving you a clear snapshot of industry suppliers — all from the convenience of your desk. Over time, our PARTNER WEEK has expanded, extending the schedule and organizing sessions by capability to make it even easier to find the right outsourcing partner for your specific needs. Plus, we’ve recently introduced STREAM by Life Science Connect — a cutting-edge platform for engaging video content in the life sciences industry. With over 40,000 webinar views in 2024, STREAM meets the growing demand for video-based learning, helping you stay informed and connected like never before. Find the right development and manufacturing partner at the upcoming OPCU in April 2025. Registration is free at the links below. - Monday, April 21, 2025 - ADC
- Tuesday, April 22, 2025 (AM) - Large Molecule Drug Substance
- Tuesday, April 22, 2025 (PM) - Bioanalytical Services
- Wednesday, April 23, 2025 - Small Molecule
- Thursday, April 24, 2025 - Cell & Gene Therapy
- Friday, April 25, 2025 - Fill/Finish
|
|
| | Lonza | Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities. | Request Information | Lonza |
|
| Lifecore Biomedical | Join Darren Hieber as he presents an overview of Lifecore Biomedical’s newly expanded capabilities, designed to meet the growing demands of innovative therapeutics. | Request Information | Lifecore Biomedical |
|
| Jubilant HollisterStier | From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision. | Request Information | Jubilant HollisterStier |
|
| FUJIFILM Diosynth Biotechnologies | Get an exclusive update on FDB’s current and future Drug Product and Finished Goods capabilities, and discover how their end-to-end CDMO services can support your next project. | Request Information | FUJIFILM Diosynth Biotechnologies |
|
| Alcami | Equipped with advanced isolator and Restricted Access Barrier Systems (RABs) technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes. | Request Information | Alcami |
|
| Ajinomoto Bio-Pharma | This presentation showcases our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges. | Request Information | Ajinomoto Bio-Pharma Services |
|
| LARGE MOLECULE DRUG SUBSTANCE & DEVELOPMENT |
|
| Northway Biotech | Over the past 20 years, we have completed more than 175 successful projects around the globe, showcasing our commitment to quality and customer satisfaction. | Request Information | Northway Biotech |
|
| Mabion | Go on a virtual tour of our GMP-certified facility, where we uphold our expanded capabilities for large molecule development to the highest standards for clinical and commercial manufacturing. | Request Information | Mabion |
|
| KBI Biopharma | Follow along as Derek Ryan, Sr. Director of Analytical Development, showcases our high-throughput tech and digital tools for process understanding and optimizing decision-making. | Request Information | KBI Biopharma |
|
| Cytovance Biologics | Here, Senior Business Development Director Rose Rhomberg showcases Cytovance’s microbial and mammalian capabilities, along with our available manufacturing capacity. | Request Information | Cytovance Biologics |
|
| Catalent | Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics. | Request Information | Catalent |
|
| | |
| Skip the lengthy vetting process and simplify your search for the perfect CDMO partner at the April 2025 OPCU virtual event! In one day, you can connect with multiple CDMOs to find the ideal fit for your project. Register now for the event! To make it even easier, OPCU is organized by capability type, so you can register for sessions tailored to the CDMOs best suited to your company’s development and manufacturing needs. - Monday, April 21, 2025 - ADC | Free Registration
- Tuesday, April 22, 2025 (AM) - Large Molecule Drug Substance | Free Registration
- Tuesday, April 22, 2025 (PM) - Bioanalytical Services | Free Registration
- Wednesday, April 23, 2025 - Small Molecule | Free Registration
- Thursday, April 24, 2025 - Cell & Gene Therapy | Free Registration
- Friday, April 25, 2025 - Fil/Finish | Free Registration
|
|
| | | Wednesday, March 19, 2025 | New York, NY CDMOs have an opportunity to win in each category in up to three groups of outsourcing respondents — Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma). We also recognize those companies that scored one standard deviation or more above the weighted average in each of the core categories. Award recipients are honored during a ceremony, after which we enjoy great food, drink, and company. Research participants, winning CDMOs, and other industry stakeholders are invited to attend. |
|
|
|
|
